医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集
▼×

糖尿病

GI Dynamics Announces Additional Members to Its Scientific Advisory Board

GI Dynamics Announces Additional Members to Its Scientific Advisory Board

ヘルスケア医療機器病院糖尿病臨床試験　 TimeLine: GI Dynamics Announces Additional Members to Its

2017年06月20日

0

GI Dynamics Announces $5m Convertible Note Financing with Crystal Amber Fund

GI Dynamics Announces $5m Convertible Note Financing with Crystal Amber Fund

ヘルスケアヘルス一般マネージド・ケア医療機器糖尿病　 TimeLine: $5m Convertible Note Financing with Crystal GI Dynamics Announces

2017年06月16日

0

Phase 1 Clinical Study Results of REMD Biotherapeutics’ Lead Product Candidate, REMD-477, Demonstrate Reduced Need for Insulin and Improved Blood Glucose Levels for Patients with Type 1 Diabetes

バイオテクノロジーヘルスケア糖尿病臨床試験製薬　 TimeLine: Blood Glucose Levels for Patients with Type Demonstrate Reduced Need for Insulin and Improved Phase 1 Clinical Study Results of REMD

2017年06月14日

0

First Data Derived from ABCD Worldwide EndoBarrier Registry Presented at ADA Shows Sustained Metabolic Improvements in Patients with Obesity and Type 2 Diabetes at Six Months Post-explant

First Data Derived from ABCD Worldwide EndoBarrier Registry Presented at ADA Shows Sustained Metabolic Improvements in Patients with Obesity and Type 2 Diabetes at Six Months Post-explant

その他ヘルスヘルスケア医療機器病院糖尿病臨床試験　 TimeLine: ADA Shows Sustained Metabolic Improvements First Data Derived from ABCD Worldwide EndoBarrier Type 2 Diabetes at Six Months Post-explant

2017年06月12日

0

GI Dynamics Releases EndoBarrier Re-Implantation Data from German Diabetes Congress

GI Dynamics Releases EndoBarrier Re-Implantation Data from German Diabetes Congress

ヘルスケアヘルス一般マネージド・ケア医療機器糖尿病　 TimeLine: GI Dynamics Releases EndoBarrier Re-Implantation

2017年06月06日

0

GI Dynamics Announces Change to Board of Directors

GI Dynamics Announces Change to Board of Directors

ヘルスケアヘルス一般マネージド・ケア医療機器糖尿病　 TimeLine: GI Dynamics Announces Change to Board

2017年06月02日

0

Meta-Analysis Show EndoBarrier Improves Glycemic Control, Induces Weight Loss in Patients with Type 2 Diabetes and Obesity

Meta-Analysis Show EndoBarrier Improves Glycemic Control, Induces Weight Loss in Patients with Type 2 Diabetes and Obesity

ヘルスケアヘルス一般マネージド・ケア医療機器糖尿病臨床試験　 TimeLine: Loss in Patients with Type 2 Diabetes Meta-Analysis Show EndoBarrier Improves Glycemic

2017年05月23日

0

Poxel Presents Imeglimin Japanese Phase 1 Results and Mechanistic Data at the 9th Scientific Meeting of the Asian Association for the Study of Diabetes in Japan

Poxel Presents Imeglimin Japanese Phase 1 Results and Mechanistic Data at the 9th Scientific Meeting of the Asian Association for the Study of Diabetes in Japan

バイオテクノロジーヘルスケア医療機器幹細胞糖尿病臨床試験製薬　 TimeLine: Data at the 9th Scientific Meeting Poxel Presents Imeglimin Japanese Phase 1 Results Study of Diabetes in Japan

2017年05月22日

0

GI Dynamics Announces Access to 2017 Annual Meeting of Stockholders and Corporate Update

GI Dynamics Announces Access to 2017 Annual Meeting of Stockholders and Corporate Update

ヘルスケア医療機器糖尿病　 TimeLine: Corporate Update GI Dynamics Announces Access to 2017 Annual

2017年05月18日

0

GI Dynamics Announces EndoBarrier CE Mark Suspension

GI Dynamics Announces EndoBarrier CE Mark Suspension

ヘルスケアヘルス一般医療機器糖尿病　 TimeLine: GI Dynamics Announces EndoBarrier CE Mark

2017年05月18日

0